Site updated at Wednesday, 22 June 2016

Living with Dementia

Immune Globulin

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   

Living With Dementia

cognitive enhancement1 - moderate severe decline1 - alzheimer's process1 - spread of alzheimers1 - single-infarct dementia1 - ßsecretase-11 - late-onset alzheimer's2 - idiocy1 - apolipoprotein1 - risk of death1 - alzheimer's treatments3 - anxiety1 - good sleep habits1 - overweight people1 - mild alzheimer's stage1 - aging and dementia1 - ucla1 - early-onset familial ad1 - brewer1 - latrepirdine1 - alzheimer's association6 - benadryl1 - diagnose parkinson's1 - frontal lobe dementia1 - experimental alzheimer's drug1 - slowed movement1 - early-onset dementia2 - blood thinning medications1 - aortic valve stenosis2 - vascular health1 -